Prostate Cancer: What’s New in Targeted Therapy and Imaging? - A Conference For Patients

Saturday, July 26th, 2014

Hughes Auditorium in the Robert H. Lurie Medical Research Bldg
303 E. Superior Street, Chicago, IL 60611

SNMMI held a collaborative 1-day conference with PCRI and UsTOO (prostate patient advocacy groups) to educate patients about new therapies and tracers available for prostate cancer patients.  To see the recordings, please click on the titles below. 


Gary Dillehay, MD
SNMMI Immediate Past-President
Professor, Dept. of Radiology, Northwestern University & Memorial Hospital

Your Chicago Support
Tom Kirk
CEO and President of Us TOO International

Patient Empowerment Perspective 
Jan Manarite
PCRI Senior Educational Facilitator (Moderator)

“Multiparametric” MRI – Targeted Biopsies & Focal Therapy
Aytekin Oto, MD
Professor of Radiology and Surgery

University of Chicago

(no recording available)

New Test for Prostate Cancer Risk and Aggressiveness  
William Catalona, MD
Professor of Urology, 
Director of Clinical Prostate Cancer Program

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Finding Metastases: PET Scans in 2014
Michael M. Graham, MD
Professor of Radiology, Director of Nuclear Medicine

University of Iowa College of Medicine in Iowa City

A Treatment Option for Bone Metastases in Prostate Cancer 
Michael Tomblyn, MD
Senior Medical Director at Bayer HealthCare

(no recording available)

Targeting Side Effects From Hormone Therapy: What Helps?
Tracey Thomas, ND
Manager of Naturopathic Residency
Cancer Treatment Centers of America, Chicago